 Sarah Royce, MD, MPH
|
| Title(s) | Assistant Clinical Professor, Epidemiology & Biostatistics |
|---|
| School | School of Medicine |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of California, San Francisco | Occupational Medicine Residency and Fellowship | 1990 | School of Medicine | | University of California, Berkeley | Masters in Public Health | 1988 | School of Public Health | | Kaiser Permanente | Internal Medicine Residency | 1987 | | | University of California, San Francisco | M.D. | 1984 | School of Medicine |
| UCSF-Clinical and Translational Science Institute | 2012
-
| 2013 | Pilot T2 (Bedside to Community) Translational Science grant (Co-investigator) |
Overview Dr. Royce is Assistant Clinical Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco (without salary). She currently works for the California Department of Health Care Services where she is Chief, Medical Quality Oversight Section of the Managed Care Quality and Monitoring Division. Before this position in Medi-Cal managed care, her career focused on tuberculosis (TB) control, from 1992-2008 as chief of the TB control branch, California Department of Public Health and then as an global TB consultant in 19 countries in Asia, Africa and Europe.
With the Cochrane HIV/AIDS Group, she led a systematic review on integration of tuberculosis and HIV services to inform the 2013 World Health Organization (WHO) consolidated guidelines on antiretroviral therapy. Dr. Royce was the lead consultant for the development of the WHO Treatment of TB guidelines. In her WHO guidelines work, she used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to rate the quality of evidence and strength of recommendations.
Dr. Royce also conducted a mixed methods study of barriers and facilitators of multidrug resistant TB case finding in Cambodia supported by a UCSF Pilot T2 (Bedside to Community) Translational Science grant. Guidelines for National Programmes.
ORNG Applications Bibliographic
-
Ehman M, Shaw T, Cass A, Lawton E, Westenhouse J, Young J, Royce S, Barry P. Developing and using performance measures based on surveillance data for program improvement in tuberculosis control. J Public Health Manag Pract. 2013 Sep-Oct; 19(5):E29-37. PMID: 23263627.
-
Cass A, Shaw T, Ehman M, Young J, Flood J, Royce S. Improved outcomes found after implementing a systematic evaluation and program improvement process for tuberculosis. Public Health Rep. 2013 Sep-Oct; 128(5):367-76. PMID: 23997283; PMCID: PMC3743285.
-
Arentz M, Pavlinac P, Kimerling ME, Horne DJ, Falzon D, Schünemann HJ, Royce S, Dheda K, Walson JL. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review. PLoS One. 2012; 7(11):e47370. PMID: 23144818; PMCID: PMC3489892.
-
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300. PMID: 22952439.
-
Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, Steingart KR. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis. 2010 Jun; 10(6):387-94. PMID: 20510279; PMCID: PMC3046810.
-
Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D. Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis. 2010 May 01; 50(9):1288-99. PMID: 20353364.
-
Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, Vernon A, Lienhardt C, Burman W. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 2009 Sep; 6(9):e1000146. PMID: 19753109; PMCID: PMC2736385.
-
Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, Vernon A, Lienhardt C. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009 Sep; 6(9):e1000150. PMID: 20101802.
-
Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J. Extensively drug-resistant tuberculosis in california, 1993-2006. Clin Infect Dis. 2008 Aug 15; 47(4):450-7. PMID: 18616396.
-
Flaherman VJ, Porco TC, Marseille E, Royce SE. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry. Pediatrics. 2007 Jul; 120(1):90-9. PMID: 17606566.
-
Porco TC, Lewis B, Marseille E, Grinsdale J, Flood JM, Royce SE. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health. 2006 Jun 19; 6:157. PMID: 16784541; PMCID: PMC1559699.
-
Pascopella L, Kellam S, Ridderhof J, Chin DP, Reingold A, Desmond E, Flood J, Royce S. Laboratory reporting of tuberculosis test results and patient treatment initiation in California. J Clin Microbiol. 2004 Sep; 42(9):4209-13. PMID: 15365013; PMCID: PMC516353.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|